Skip to main content

Advertisement

SpringerLink
Log in

Migraine with and without aura and risk for cardiovascular disease

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Migraine, cardiovascular disease, and stroke are three highly prevalent and disabling conditions that exert a significant socioeconomic impact. The association between migraine and a twofold risk of stroke and myocardial infarction has been the topic of much debate. The mechanism underlying this link is largely unknown but may be the result of an increased prevalence of other conditions such as vasculopathies, hypercoagulable states, and patent foramen ovale seen in migraine with aura. Although many prior studies have demonstrated increased risks in women with migraine with aura, an emerging body of evidence is showing similar risks in men. These risks are further compounded with increased migraine frequency, smoking, and the use of oral contraceptive pills. Because the overall risk for stroke and myocardial infarction in migraineurs remains relatively low, recommendations at this time are limited to the modification of cardiovascular risk factors, such as smoking cessation and the avoidance of oral contraceptive pills, especially in women suffering from migraine with aura.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Lipton RB, Bigal ME, Diamond M, et al.: Migraine prevalence, disease burden, and the need for preventative therapy. Neurology 2007, 68:343–349.

    Article  PubMed  CAS  Google Scholar 

  2. Rosamond W, Flegal K, Friday G, et al.: Heart disease and stroke statistics — 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69–e171.

    Article  PubMed  Google Scholar 

  3. Vahedi K, Chabriat H, Levy C, et al.: Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol 2004, 61:1237–1240.

    Article  PubMed  Google Scholar 

  4. Pavlakis SG, Phillips PC, DiMauro S, et al.: Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes: a distinctive clinical syndrome. Ann Neurol 1984, 16:481–488.

    Article  PubMed  CAS  Google Scholar 

  5. Scher AI, Terwindt GM, Verschuren WM, et al.: Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 2006, 59:372–375.

    Article  PubMed  CAS  Google Scholar 

  6. Pezzini A, Granella F, Grassi M, et al.: History of migraine and the risk of spontaneous cervical artery dissection. Cephalalgia 2005, 25:575–580.

    Article  PubMed  CAS  Google Scholar 

  7. Diener HC, Kurth T, Dodick D: Patent foramen ovale, stroke, and cardiovascular disease in migraine. Curr Opin Neurol 2007, 20:310–319.

    Article  PubMed  Google Scholar 

  8. Kovács K, Hermán F, Filep J, et al.: Platelet aggregation of migraineurs during and between attacks. Cephalalgia 1990, 10:161–165.

    Article  PubMed  Google Scholar 

  9. Tietjen GE, Al-Qasmi MM, Athanas K, et al.: Increased von Willebrand factor in migraine. Neurology 2001, 57:334–336.

    PubMed  CAS  Google Scholar 

  10. O’Keeffe ST, Tsapatsaris NP, Beetham WP Jr: Increased prevalence of migraine and chest pain in patients with primary Raynaud disease. Ann Intern Med 1992, 116:985–989.

    PubMed  CAS  Google Scholar 

  11. Scher AI, Terwindt GM, Picavet HS, et al.: Cardiovascular risk factors and Migraine. The GEM population-based study. Neurology 2005, 64:614–620.

    PubMed  CAS  Google Scholar 

  12. Henry KA, Vargas BB: Migraine: not just your mother’s headache anymore. Neurology 2007, 68:319.

    Article  Google Scholar 

  13. Brown DL, Boden-Albala B, Langa KM, et al.: Projected costs of ischemic stroke in the United States. Neurology 2006, 67:1390–1395.

    Article  PubMed  CAS  Google Scholar 

  14. Kurth T, Gaziano JM, Cook NR, et al.: Migraine and risk of cardiovascular disease in women. JAMA 2006, 296:283–291.

    Article  PubMed  CAS  Google Scholar 

  15. Kurth T, Gaziano JM, Cook NR, et al.: Migraine and risk of cardiovascular disease in men. Arch Intern Med 2007, 167:795–801.

    Article  PubMed  Google Scholar 

  16. Waters WE, Campbell MJ, Elwood PC: Migraine, headache, and survival in women. BMJ (Clin Res Ed) 1983, 287:1442–1443.

    Article  CAS  Google Scholar 

  17. Liew G, Wang JJ, Mitchell P: Migraine and coronary heart disease mortality: a prospective cohort study. Cephalalgia 2007, 27:368–371.

    Article  PubMed  CAS  Google Scholar 

  18. Etminan M, Takkouche B, Isorna FC, Samii A: Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005, 330:63–66.

    Article  PubMed  Google Scholar 

  19. Becker C, Brobert G, Almqvist PM, et al.: Migraine and the risk of stroke, TIA, or death in the UK. Headache 2007, 47:1374–1384.

    PubMed  Google Scholar 

  20. MacClellan LR, Giles W, Cole J, et al.: Probable migraine with visual aura and risk of ischemic stroke: the Stroke Prevention in Young Women study. Stroke 2007, 38:2438–2445.

    Article  PubMed  Google Scholar 

  21. Kurth T, Schürks M, Logroschino G, Buring JE: Migraine frequency and risk of cardiovascular disease in women [abstract]. Neurology 2008, 70(Suppl 1):A403.

    Google Scholar 

  22. Vanmolkot FH, Van Bortel LM, de Hoon JN: Altered arterial function in migraine of recent onset. Neurology 2007, 68:1563–1570.

    Article  PubMed  Google Scholar 

  23. Lee ST, Chu K, Jung KH, et al.: Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology 2008, 70:1510–1517.

    Article  PubMed  Google Scholar 

  24. Asahara T, Murohara T, Sullivan A, et al.: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964–967.

    Article  PubMed  CAS  Google Scholar 

  25. Hill JM, Zalos G, Halcox JP, et al.: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593–600.

    Article  PubMed  Google Scholar 

  26. Sobrino T, Hurtado O, Moro MA, et al.: The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke 2007, 38:2759–2764.

    Article  PubMed  Google Scholar 

  27. Kurth K, Ridker PM, Buring JE: Migraine and biomarkers of cardiovascular disease in women. Cephalalgia 2007, 28:49–56.

    PubMed  Google Scholar 

  28. Overell JR, Bone I, Lees KR: Interatrial septal abnormalities and stroke: a meta-analysis of case control studies. Neurology 2000, 55:1172–1179.

    PubMed  CAS  Google Scholar 

  29. Schwedt TJ, Demaerschalk BM, Dodick DW: Patent formen ovale and migraine: a quantitative systematic review. Cephalalgia 2008, 28:531–540.

    Article  PubMed  CAS  Google Scholar 

  30. Wingerchuk DM, Spencer B, Dodick DW, Demaerschalk BM: Migraine with aura is a risk factor for cardiovascular and cerebrovascular disease: a critically appraised topic. Neurologist 2007, 13:231–233.

    Article  PubMed  Google Scholar 

  31. Bousser MG, Conard J, de Kittner S, et al.: Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. Cephalalgia 2000, 20:155–156.

    Article  PubMed  CAS  Google Scholar 

  32. ACOG Practice Bulletin: The use of hormonal contraception in women with coexisting medical conditions. Int J Gynaecol Obstet 2001, 75:93–106.

    Article  Google Scholar 

  33. Curtis KM, Mohllajee AP, Peterson HB: Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review. Contraception 2006, 73:189–194.

    Article  PubMed  CAS  Google Scholar 

  34. Tietjen GE: Migraine and ischaemic heart disease and stroke: potential mechanisms and treatment implications. Cephalalgia 2007, 27:981–987.

    Article  PubMed  Google Scholar 

  35. Hall GC, Brown MM, Mo J, MacRae KD: Triptans in migraine. The risks of stroke, cardiovascular disease, and death in practice. Neurology 2004, 62:563–568.

    PubMed  CAS  Google Scholar 

  36. Papademetriou V: Cardiovascular risk assessment and triptans. Headache 2004, 44(Suppl 1):S31–S39.

    Article  PubMed  Google Scholar 

  37. Dodick DW, Martin VT, Smith T, Silberstein S: Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache 2004, 44(Suppl 1):S20–S30.

    Article  PubMed  Google Scholar 

  38. Kurth T, Slomke MA, Kase CS, et al.: Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005, 64:1020–1026.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Mayo Clinic Hospital, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, USA

    Bert B. Vargas

Authors
  1. Bert B. Vargas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David W. Dodick
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dean M. Wingerchuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bart M. Demaerschalk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bert B. Vargas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vargas, B.B., Dodick, D.W., Wingerchuk, D.M. et al. Migraine with and without aura and risk for cardiovascular disease. Curr Atheroscler Rep 10, 427–433 (2008). https://doi.org/10.1007/s11883-008-0065-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-008-0065-4

Keywords

Search

Navigation